Reducing Cardiovascular Disease—An Alternative Approach

Purpose Statin drugs are effective at reducing cardiovascular events, but adherence to statin therapy remains a problem for patients and their physicians. We review a paper estimating the economic costs of poor adherence to statin drugs. Methods The authors examined two large databases (Medicare and...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 2024-12, Vol.38 (6), p.1083-1087
Main Authors: Boricha, Hetal, Blankenship, James C., Schade, David S.
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular diseases
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - prevention & control
Databases, Factual
Drugs
Dyslipidemias - drug therapy
Economic impact
Editorial
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Lipids
Medication Adherence
Medicine
Medicine & Public Health
Myocardial infarction
Risk management
Therapy
Treatment Outcome
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Statin drugs are effective at reducing cardiovascular events, but adherence to statin therapy remains a problem for patients and their physicians. We review a paper estimating the economic costs of poor adherence to statin drugs. Methods The authors examined two large databases (Medicare and Market Scan databases) including 230,000 patients with hospitalization for myocardial infarction between 2018 and 2019 to determine how many patients were not adhering to guideline-recommended anti-hyperlipidemic medications. They have also calculated the potential consequences of patients who are not adhering to the recommended therapy. Results The authors estimate that if all patients were receiving guideline-directed medical therapy, then a 22% relative risk reduction would occur in the 3-year period following discharge from the initial cardiovascular event. These findings are consistent with prior reports. This editorial discusses rationale and strategies clinicians can use to improve patients’ compliance with recommendations for lipid-lowering therapy. Conclusion The authors conclude that better compliance with guideline-directed lipid therapy after a cardiovascular event would lead to a large reduction in second events. Increased efforts by clinicians to improve adherence to statin therapy are warranted.
ISSN:0920-3206
1573-7241
1573-7241
DOI:10.1007/s10557-024-07600-1